RARA and cancer: Since ASC1 ufmylation can be achieved by specific ligands for other nuclear receptors, such as AR and RARα, it would be of interest to examine whether ASC1 ufmylation also promotes the transcriptional activity of the nuclear receptors and thereby the receptor-mediated cancers, such as prostate and leukemic cancers, respectively.